LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
1-Year Return
5.19%
This Quarter Return
-1.67%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.07B
AUM Growth
-$529M
(-15%)
Cap. Flow
-$327M
Cap. Flow
% of AUM
-10.65%
Top 10 Holdings %
Top 10 Hldgs %
53.48%
Holding
600
New
258
Increased
39
Reduced
96
Closed
156
Top Buys
| 1 |
HES
Hess
HES
|
$346M |
| 2 |
X
US Steel
X
|
$170M |
| 3 |
HubSpot
HUBS
|
$167M |
| 4 |
ANSS
Ansys
ANSS
|
$166M |
| 5 |
Chevron
CVX
|
$141M |
Top Sells
| 1 |
Kenvue
KVUE
|
$128M |
| 2 |
Adobe
ADBE
|
$97.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$84M |
| 4 |
BP
BP
|
$78.5M |
| 5 |
Apple
AAPL
|
$71.3M |
Sector Composition
| 1 | Technology | 29.42% |
| 2 | Healthcare | 20.77% |
| 3 | Energy | 16.72% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Financials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$71.3M
| $145K | ﹤0.01% |
16,666
| – | – |
|
377
Roivant Sciences
ROIV
$8.82B
| $142K | ﹤0.01% |
+13,397
| New | +$142K |
|
378
Grindr
GRND
$2.94B
| $142K | ﹤0.01% |
+11,564
| New | +$142K |
|
379
Clarivate
CLVT
$2.96B
| $138K | ﹤0.01% |
+24,294
| New | +$138K |
|
380
Emergent Biosolutions
EBS
$404M
| $132K | ﹤0.01% |
+19,302
| New | +$132K |
|
381
Aemetis
AMTX
$151M
| $122K | ﹤0.01% |
40,536
-284,260
| -88% | -$856K |
|
382
Marcus Corp
MCS
$483M
| $121K | ﹤0.01% |
+10,657
| New | +$121K |
|
383
Provident Bancorp
PVBC
$229M
| $120K | ﹤0.01% |
11,752
-23,506
| -67% | -$240K |
|
384
AvePoint
AVPT
$3.45B
| $119K | ﹤0.01% |
+11,402
| New | +$119K |
|
385
1stdibs.com
DIBS
$100M
| $116K | ﹤0.01% |
25,805
-51,610
| -67% | -$232K |
|
386
Rekor Systems
REKR
$138M
| $115K | ﹤0.01% |
74,052
-524,848
| -88% | -$814K |
|
387
Cogent Biosciences
COGT
$1.82B
| $115K | ﹤0.01% |
+13,612
| New | +$115K |
|
388
Dynavax Technologies
DVAX
$1.18B
| $114K | ﹤0.01% |
+10,169
| New | +$114K |
|
389
Ironwood Pharmaceuticals
IRWD
$188M
| $110K | ﹤0.01% |
+16,841
| New | +$110K |
|
390
Ginkgo Bioworks
DNA
$660M
| $107K | ﹤0.01% |
+8,006
| New | +$107K |
|
391
Travere Therapeutics
TVTX
$1.93B
| $91.7K | ﹤0.01% |
+11,157
| New | +$91.7K |
|
392
Editas Medicine
EDIT
$248M
| $82.4K | ﹤0.01% |
+17,648
| New | +$82.4K |
|
393
Nucor
NUE
$33.8B
| $79.5K | ﹤0.01% |
503
-23,574
| -98% | -$3.73M |
|
394
ON Semiconductor
ON
$20.1B
| $78.1K | ﹤0.01% |
+1,140
| New | +$78.1K |
|
395
Genworth Financial
GNW
$3.52B
| $73.6K | ﹤0.01% |
+12,189
| New | +$73.6K |
|
396
Outset Medical
OM
$249M
| $70.2K | ﹤0.01% |
+1,215
| New | +$70.2K |
|
397
Navitas Semiconductor
NVTS
$1.19B
| $60.4K | ﹤0.01% |
+15,374
| New | +$60.4K |
|
|
CTEV
398
Claritev Corporation
CTEV
$1.15B
| $55.5K | ﹤0.01% |
+3,571
| New | +$55.5K |
|
399
Gevo
GEVO
$404M
| $49K | ﹤0.01% |
+87,913
| New | +$49K |
|
400
eHealth
EHTH
$125M
| $46.8K | ﹤0.01% |
+10,340
| New | +$46.8K |
|